We are live on
!
Find out more
WP
Woodline Partners Portfolio holdings
AUM
$26.4B
1-Year Est. Return
44.85%
This Fund
S&P 500
This Quarter
Est. Return
+11.56%
1 Year Est. Return
+44.85%
3 Year Est. Return
+131.23%
5 Year Est. Return
+174.12%
10 Year Est. Return
–
AUM
$8.44B
AUM Growth
+$1.09B
(+15%)
Cap. Flow
+$577M
Cap. Flow
% of AUM
6.84%
Top 10 Holdings %
Top 10 Hldgs %
15.63%
Holding
838
New
218
Increased
181
Reduced
162
Closed
220
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$123M |
| 2 |
HES
Hess
HES
|
+$115M |
| 3 |
ATVI
Activision Blizzard
ATVI
|
+$108M |
| 4 |
Cencora
COR
|
+$106M |
| 5 |
Microsoft
MSFT
|
+$101M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Baxter International
BAX
|
+$108M |
| 2 |
Analog Devices
ADI
|
+$105M |
| 3 |
Keysight
KEYS
|
+$101M |
| 4 |
Regeneron Pharmaceuticals
REGN
|
+$82.2M |
| 5 |
Booking.com
BKNG
|
+$58.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 37.55% |
| 2 | Technology | 28% |
| 3 | Industrials | 9.43% |
| 4 | Energy | 7.74% |
| 5 | Consumer Discretionary | 5.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HZNP
51
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $40.4M | 0.48% |
392,763
+28,029
| +8% | +$2.96M |
|
52
Gulfport Energy Corp
GPOR
$2.9B
| $40.3M | 0.48% |
+383,870
| New | +$35.6M |
|
|
UNVR
53
DELISTED
Univar Solutions Inc.
UNVR
| $39.6M | 0.47% |
1,105,500
+703,500
| +175% | +$25M |
|
|
INBX
54
DELISTED
Inhibrx, Inc. Common Stock
INBX
| $39.6M | 0.47% |
1,524,915
+1,210,720
| +385% | +$28.3M |
|
55
Roivant Sciences
ROIV
$24.5B
| $38.3M | 0.45% |
3,796,871
+236,320
| +7% | +$2.11M |
|
56
Nutanix
NTNX
$16B
| $38.3M | 0.45% |
1,363,692
+655,006
| +92% | +$17.4M |
|
57
Alphabet (Google) Class A
GOOGL
$4.36T
| $37.3M | 0.44% |
+311,506
| New | +$35.9M |
|
58
Boston Scientific
BSX
$69.5B
| $37.2M | 0.44% |
688,386
-194,642
| -22% | -$10.2M |
|
59
Cigna
CI
$73.7B
| $34.9M | 0.41% |
+124,288
| New | +$32.4M |
|
|
LSXMA
60
DELISTED
Liberty Media Corporation Series A Liberty SiriusXM Common Stock
LSXMA
| $34.8M | 0.41% |
1,442,689
-242,011
| -14% | -$5.15M |
|
|
61
Regeneron Pharmaceuticals
REGN
$78.5B
| $34.2M | 0.41% |
47,662
-106,659
| -69% | -$82.2M |
|
62
CDW
CDW
$18.9B
| $34.2M | 0.41% |
+186,411
| New | +$32.6M |
|
63
Arista Networks
ANET
$227B
| $33.5M | 0.4% |
+826,200
| New | +$31.9M |
|
64
Automatic Data Processing
ADP
$106B
| $33.2M | 0.39% |
151,173
+12,657
| +9% | +$2.73M |
|
65
Pinterest
PINS
$13.4B
| $33.1M | 0.39% |
1,210,081
+6,537
| +0.5% | +$163K |
|
66
Flex
FLEX
$41.7B
| $32.8M | 0.39% |
1,574,650
+947,307
| +151% | +$16.9M |
|
67
Uber
UBER
$143B
| $32.4M | 0.38% |
+750,600
| New | +$27.9M |
|
68
Globant
GLOB
$1.58B
| $32.1M | 0.38% |
178,400
+63,269
| +55% | +$10.4M |
|
69
Becton Dickinson
BDX
$45.6B
| $32M | 0.38% |
121,195
-119,058
| -50% | -$30.2M |
|
70
F5
FFIV
$22.9B
| $31.9M | 0.38% |
218,189
+178,964
| +456% | +$25.4M |
|
71
Axsome Therapeutics
AXSM
$11.2B
| $31.6M | 0.37% |
439,925
-130,900
| -23% | -$9.66M |
|
|
CPE
72
DELISTED
Callon Petroleum Company
CPE
| $31.5M | 0.37% |
+899,000
| New | +$30.1M |
|
73
Incyte
INCY
$24.2B
| $31.1M | 0.37% |
500,000
-92,756
| -16% | -$6.2M |
|
|
AVDL
74
DELISTED
Avadel Pharmaceuticals
AVDL
| $31M | 0.37% |
1,879,343
| – | – |
|
75
Zentalis Pharmaceuticals
ZNTL
$337M
| $30.9M | 0.37% |
1,094,974
-1,070,577
| -49% | -$25.7M |
|
Similar funds
PAM
TCIIS
UIM
Woodline Partners's Q2 2023 Portfolio in Review
As of Q2 2023, Woodline Partners held 838 positions worth $8.44B, up 15% from $7.35B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Woodline Partners deployed $577M of net new capital in Q2 2023, opening 218 new positions and adding to 181 existing holdings. Its largest new stake was Hess: 837,083 shares worth $114M.
By sector, the portfolio is most concentrated in Healthcare at 38% of assets, up from 35% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was Keysight, an estimated $101M trimmed.
- Woodline Partners's largest Q2 2023 buy was Hess: 837,083 shares worth $114M.
- Woodline Partners added most to Johnson & Johnson in Q2 2023, an estimated $123M increase.
- Woodline Partners's biggest Q2 2023 reduction was Keysight, cutting an estimated $101M.
- Woodline Partners fully exited Baxter International in Q2 2023, selling an estimated $108M.
- Woodline Partners's ten largest holdings make up 16% of its $8.44B portfolio in Q2 2023.
- Woodline Partners opened 218 new positions and closed 220 in Q2 2023.
- Woodline Partners's portfolio value rose 15% quarter-over-quarter to $8.44B.
Based on Woodline Partners's 13F filing for Q2 2023, filed 14 Aug 2023.